Market Access Growth Leverage DRG’s strength in market access and payer dynamics to offer enhanced payer negotiation support, local access optimization, and real-world evidence generation for pharma and device clients. Position as a partner that accelerates evidence-based commercialization by pairing DRG’s insights with advanced analytics. This creates opportunities to cross-sell data enrichment and payer landscape services to DRG’s life sciences customers.

AIDriven Analytics DRG’s use of artificial intelligence and machine learning for evidence-based decisions opens doors for scalable data science collaborations. Propose providing advanced analytics platforms, predictive models, and seamless data integration to augment DRG’s existing offerings for life sciences clients. The goal is faster, more precise market access forecasting and commercialization planning.

Oncology Navigator The Market Access Disease Navigator signals DRG’s focus on complex oncology market dynamics. Upsell additional modules or disease-area expansions with tailored payer and health-system insights to support launches and pricing strategies. This aligns with pharma clients seeking rapid, local-market evidence to optimize access and reimbursement.

Regional Focus Massachusetts base creates strong regional sales and collaboration opportunities with New England health systems, hospitals, and payers. Propose joint pilots and regional data offerings to accelerate patient access initiatives and value-based care programs for DRG’s clientele. Local market intelligence can shorten sales cycles and improve engagement with regional stakeholders.

Clarivate Synergy Being part of Clarivate’s portfolio presents a path to cross-sell into Clarivate’s life sciences and pharmaceutical customer base. Offer bundled insights and joint go-to-market strategies that combine DRG’s market access and data analytics with Clarivate’s broader analytics ecosystem to expand reach and deepen client adoption.